Aclaris Therapeutics Statistics
Total Valuation
ACRS has a market cap or net worth of $239.72 million. The enterprise value is $68.53 million.
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACRS has 107.02 million shares outstanding. The number of shares has increased by 3.48% in one year.
| Current Share Class | 107.02M |
| Shares Outstanding | 107.02M |
| Shares Change (YoY) | +3.48% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 2.64% |
| Owned by Institutions (%) | 46.27% |
| Float | 65.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.89 |
| Forward PS | 28.16 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.03, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.03 |
| Quick Ratio | 6.81 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.83% and return on invested capital (ROIC) is -26.72%.
| Return on Equity (ROE) | -25.83% |
| Return on Assets (ROA) | -19.39% |
| Return on Invested Capital (ROIC) | -26.72% |
| Return on Capital Employed (ROCE) | -38.01% |
| Revenue Per Employee | $297,571 |
| Profits Per Employee | -$406,637 |
| Employee Count | 91 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -367,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +85.12% in the last 52 weeks. The beta is 0.52, so ACRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +85.12% |
| 50-Day Moving Average | 2.63 |
| 200-Day Moving Average | 1.82 |
| Relative Strength Index (RSI) | 39.59 |
| Average Volume (20 Days) | 656,603 |
Short Selling Information
The latest short interest is 3.92 million, so 3.66% of the outstanding shares have been sold short.
| Short Interest | 3.92M |
| Short Previous Month | 3.39M |
| Short % of Shares Out | 3.66% |
| Short % of Float | 6.00% |
| Short Ratio (days to cover) | 4.10 |
Income Statement
In the last 12 months, ACRS had revenue of $27.08 million and -$37.00 million in losses. Loss per share was -$0.52.
| Revenue | 27.08M |
| Gross Profit | -76.91M |
| Operating Income | -62.18M |
| Pretax Income | -59.05M |
| Net Income | -37.00M |
| EBITDA | -62.20M |
| EBIT | -62.18M |
| Loss Per Share | -$0.52 |
Full Income StatementBalance Sheet
The company has $127.72 million in cash and $2.25 million in debt, giving a net cash position of $171.19 million or $1.60 per share.
| Cash & Cash Equivalents | 127.72M |
| Total Debt | 2.25M |
| Net Cash | 171.19M |
| Net Cash Per Share | $1.60 |
| Equity (Book Value) | 130.15M |
| Book Value Per Share | 1.82 |
| Working Capital | 113.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.90 million and capital expenditures -$562,000, giving a free cash flow of -$18.46 million.
| Operating Cash Flow | -17.90M |
| Capital Expenditures | -562,000 |
| Free Cash Flow | -18.46M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
Gross margin is -284.04%, with operating and profit margins of -229.61% and -136.65%.
| Gross Margin | -284.04% |
| Operating Margin | -229.61% |
| Pretax Margin | -138.01% |
| Profit Margin | -136.65% |
| EBITDA Margin | -229.71% |
| EBIT Margin | -229.61% |
| FCF Margin | n/a |
Dividends & Yields
ACRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.48% |
| Shareholder Yield | -3.48% |
| Earnings Yield | -15.44% |
| FCF Yield | -7.70% |
Analyst Forecast
The average price target for ACRS is $11.00, which is 391.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 391.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 32.94% |
| EPS Growth Forecast (5Y) | -6.91% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACRS has an Altman Z-Score of -5.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.06 |
| Piotroski F-Score | 3 |